Who
Elizabeth A. Grammer
Director
Company insider
Files Form 4 as: Director, Sagimet Biosciences; EVP, General Counsel, Ardelyx.
In numbers
- Trades disclosed
- 124
- Buys
- 2
- Sells
- 46
- Bought
- $2,356
- Sold
- $5.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 6 Jan 2015
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,567 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,567 at $0.00 | filing |
| 21 Nov 2025filed 25 Nov 2025 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $33K5,995 at $5.54 | filing |
| 21 Aug 2025filed 25 Aug 2025 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $35K5,841 at $5.93 | filing |
| 9 Jun 2025filed 10 Jun 2025 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,250 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $24K5,992 at $4.08 | filing |
| 25 Feb 2025filed 27 Feb 2025 | ARDX Ardelyxoption or derivative · Biotechnology | SEC FORM 4 Code A | —205,019 at $0.00 | filing |
| 25 Feb 2025filed 27 Feb 2025 | ARDX ArdelyxBiotechnology | SEC FORM 4 Code A | —136,680 at $0.00 | filing |
| 20 Feb 2025filed 21 Feb 2025 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $24K4,291 at $5.62 | filing |
| 20 Nov 2024filed 22 Nov 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $34K7,046 at $4.79 | filing |
| 20 Aug 2024filed 22 Aug 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $42K7,089 at $5.86 | filing |
| 5 Jun 2024filed 7 Jun 2024 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,459 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $54K6,927 at $7.81 | filing |
| 6 May 2024filed 9 May 2024 | ARDX Ardelyxoption or derivative · Biotechnology | SEC FORM 4 Code M | —110,250 at $0.00 | filing |
| 6 May 2024filed 9 May 2024 | ARDX Ardelyxoption or derivative · Biotechnology | SEC FORM 4 Code M | —109,687 at $0.00 | filing |
| 6 May 2024filed 9 May 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Code M | $109K110,250 at $0.99 | filing |
| 6 May 2024filed 9 May 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Code M | $302K109,687 at $2.75 | filing |
| 6 May 2024filed 9 May 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $570K64,233 at $8.87 | filing |
| 6 May 2024filed 9 May 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $2.0M219,937 at $8.88 | filing |
| 3 May 2024filed 7 May 2024 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $405K45,000 at $9.00 | filing |
News
November 16, 2026 Deadline: Join Class Action Lawsuit Against Ardelyx, ...ARDX · pr-inside.com · 20 Oct 2026ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallStARDX · prnewswire.com · 15 Oct 2026ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your LossesARDX · prnewswire.com · 14 Oct 2026
0 headlines in the last 90 days name Elizabeth A. Grammer; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.